Journal Report Says Prompt Diagnosis Key to Surviving Bladder Cancer, According to Cancer Monthly

April 2, 2014

A new UK report on the early warning signs of bladder cancer is especially relevant for diabetics and those who have taken Actos.

Raleigh, NC (PRWEB) April 02, 2014

A newly published report prepared by a team of medical oncologists in the UK says early recognition of bladder cancer symptoms could be the difference between life and death. A new article on the report has just been posted on the Cancer Monthly website and can be read by clicking here.

Drs. Karen DeSouza, Simon Chowdhury and Simon Hughes are medical oncology consultants who work with several top hospitals in the UK. In their new summary of bladder cancer symptoms, they note that people with type 2 diabetes – especially those who have been treated with Actos (pioglitazone) – are at increased risk of bladder cancer and should be particularly aware of the signs.

“Delayed diagnosis is associated with high-grade muscle invasive disease which has the potential to progress rapidly, metastasize and is often fatal,” observes lead author Dr. DeSouza. “Haematuria [blood in the urine]…is the classical and most common presentation of bladder cancer.”

The study, published in the journal Practitioner, details the other key symptoms of bladder cancer and suggests what the authors consider the most important laboratory tests for diabetics and others who think they may have the disease.

“This article is just another reminder of how important it is to pay attention to early symptoms of bladder cancer,” says Alex Strauss, Managing Editor of Cancer Monthly. “Diabetics and anyone who has taken Actos owe it to themselves to know the signs.”

To read more of the British researchers’ conclusions and see their detailed list of bladder cancer warning signs, see Oncologists Say Early Detection Key to Bladder Cancer Survival, now available on the Cancer Monthly website.

DeSouza, K, Chowdhury, S, Hughes, S, “Prompt diagnosis key in bladder cancer”, Practitioner, January 2014, pp. 23-27, http://www.ncbi.nlm.nih.gov/pubmed/24617100

For over ten years, Cancer Monthly has been the only centralized source of cancer treatment results. Patients can see the actual survival rate, quality-of-life indicators, and other key data for approximately 1,500 different cancer treatments. Cancer Monthly provides timely and ground-breaking news on the causes, diagnoses and treatments of the most common cancers including Bladder, Brain, Breast, Colon, Kidney (Renal), Liver, Lung (NSCLC), Ovarian, Prostate and Rectal Cancers, Melanoma, Mesothelioma, and Non-Hodgkin's Lymphoma. Written for patients and their loved ones, Cancer Monthly helps families make more informed treatment decisions.

For the original version on PRWeb visit: http://www.prweb.com/releases/2014/03/prweb11715160.htm

Source: prweb

comments powered by Disqus